Business Standard

Vaccine working on new variants next challenge: SII CEO Adar Poonawalla

'We are delivering 220 million doses a month, and almost everything is being consumed', said Poonawalla

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das
Having supplied more than 90 per cent of India’s vaccine doses, Serum Institute of India (SII) played a pivotal role in ensuring the country reached the milestone of 1 billion jabs. SII CEO Adar Poonawalla tells Sohini Das that India now has 3-4 weeks’ buffer stock, and exports will pick up in January. Edited excerpts:

You are supplying over 200 million doses a month. How did you plan the scale up?

We had taken a lot of risk and planned our execution in early 2020. The fruits of that labour are finally showing. All the other vaccine manufacturers will also

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in